These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
991 related articles for article (PubMed ID: 31486477)
1. MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1. Luo B; Yang JF; Wang YH; Qu GB; Hao PD; Zeng ZJ; Yuan J; Yang R; Yuan Y Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6791-6799. PubMed ID: 31486477 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression. Zhou JG; Hua Y; Liu SW; Hu WQ; Qian R; Xiong L Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):1-10. PubMed ID: 31957812 [TBL] [Abstract][Full Text] [Related]
3. MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs. Chen R; Qiu H; Tong Y; Liao F; Hu X; Qiu Y; Liao Y Biochem Biophys Res Commun; 2019 Aug; 516(3):666-672. PubMed ID: 31248594 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells. Lv R; Pan X; Song L; Sun Q; Guo C; Zou S; Zhou Q Biomed Pharmacother; 2019 Aug; 116():108960. PubMed ID: 31112871 [TBL] [Abstract][Full Text] [Related]
5. MiRNA-27a-3p promotes osteogenic differentiation of human mesenchymal stem cells through targeting ATF3. Fu YC; Zhao SR; Zhu BH; Guo SS; Wang XX Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):73-80. PubMed ID: 31389577 [TBL] [Abstract][Full Text] [Related]
6. Teriparatide alleviates osteoporosis by promoting osteogenic differentiation of hMSCs via miR-375/RUNX2 axis. Lei NB; Liang X; Wang P; Liu Q; Wang WG Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):11043-11050. PubMed ID: 31858576 [TBL] [Abstract][Full Text] [Related]
7. Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5. Zhou J; Nie H; Liu P; Wang Z; Yao B; Yang L Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):29-36. PubMed ID: 30657543 [TBL] [Abstract][Full Text] [Related]
8. MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2. Cheng F; Yang MM; Yang RH Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7766-7774. PubMed ID: 31599402 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-449b-5p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of BMSCs via targeting Satb2. Li JY; Wei X; Sun Q; Zhao XQ; Zheng CY; Bai CX; Du J; Zhang Z; Zhu LG; Jia YS Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6394-6403. PubMed ID: 31378877 [TBL] [Abstract][Full Text] [Related]
10. LncRNA GAS5 overexpression alleviates the development of osteoporosis through promoting osteogenic differentiation of MSCs via targeting microRNA-498 to regulate RUNX2. Feng J; Wang JX; Li CH Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7757-7765. PubMed ID: 31599401 [TBL] [Abstract][Full Text] [Related]
11. microRNA-29b-3p/sirtuin-1/peroxisome proliferator-activated receptor γ suppress osteogenic differentiation. Xie H; Cao L; Ye L; Li Q; Zhang Y; Zhang H; Yang H In Vitro Cell Dev Biol Anim; 2023 Feb; 59(2):109-120. PubMed ID: 36881345 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-7-5p regulates osteogenic differentiation of hMSCs via targeting CMKLR1. Chen B; Meng J; Zeng YT; Du YX; Zhang J; Si YM; Yuan X Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7826-7831. PubMed ID: 30536327 [TBL] [Abstract][Full Text] [Related]
13. microRNA-1297 promotes the progression of osteoporosis through regulation of osteogenesis of bone marrow mesenchymal stem cells by targeting WNT5A. Wang Q; Wang CH; Meng Y Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4541-4550. PubMed ID: 31210281 [TBL] [Abstract][Full Text] [Related]
14. A novel miR-466l-3p/FGF23 axis promotes osteogenic differentiation of human bone marrow mesenchymal stem cells. Zhang X; Xu J Bone; 2024 Aug; 185():117123. PubMed ID: 38735373 [TBL] [Abstract][Full Text] [Related]
15. microRNA-25-3p suppresses osteogenic differentiation of BMSCs in patients with osteoporosis by targeting ITGB3. Yu D; Li Z; Cao J; Shen F; Wei G Acta Histochem; 2022 Aug; 124(6):151926. PubMed ID: 35777302 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA miR-874-3p inhibits osteoporosis by targeting leptin (LEP). Mei L; Li M; Zhang T Bioengineered; 2021 Dec; 12(2):11756-11767. PubMed ID: 34818977 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-9-5p promotes osteoporosis development through inhibiting osteogenesis and promoting adipogenesis via targeting Wnt3a. Zhang HG; Wang XB; Zhao H; Zhou CN Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):456-463. PubMed ID: 30720151 [TBL] [Abstract][Full Text] [Related]
18. MiRNA-7b-5p attenuates the progression of osteoporosis by inhibiting adipose differentiation of hMSCs via regulating IRS2. Li QQ; Wei Q; Zhai XC; Qin L; Li HB; Meng R; Chen SC Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9207-9214. PubMed ID: 31773671 [TBL] [Abstract][Full Text] [Related]
19. MiR-210 promotes bone formation in ovariectomized rats by regulating osteogenic/adipogenic differentiation of bone marrow mesenchymal stem cells through downregulation of EPHA2. Ren L; Zhu X; Tan J; Lv X; Wang J; Hua F J Orthop Surg Res; 2023 Oct; 18(1):811. PubMed ID: 37904187 [TBL] [Abstract][Full Text] [Related]